Drug Profile
Research programme: histamine H1 receptor antagonists - Esteve
Alternative Names: Histamine H1 receptor antagonists research programme - EsteveLatest Information Update: 05 Dec 2006
Price :
$50
*
At a glance
- Originator Esteve
- Class
- Mechanism of Action Histamine H1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 14 Aug 2001 No-Development-Reported for Asthma in Spain (Unknown route)
- 14 Oct 1998 Preclinical development for Asthma in Spain (Unknown route)